Allspring Global Investments
RCKT icon

Allspring Global Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Allspring Global Investments’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20
Closed -$369 – 2267
2024
Q3 		$369 Hold
20
– – ﹤0.01% 2383
2024
Q2 		$430 Buy
+20
New +$459 ﹤0.01% 2318
2023
Q4 		– Sell
-5,145
Closed -$105K – 2640
2023
Q3 		$105K Buy
5,145
+633
+14% +$11.5K ﹤0.01% 1984
2023
Q2 		$89.7K Sell
4,512
-567
-11% -$11.5K ﹤0.01% 2096
2023
Q1 		$87K Buy
5,079
+3,351
+194% +$65.6K ﹤0.01% 2095
2022
Q4 		$33.8K Sell
1,728
-38
-2% -$700 ﹤0.01% 2451
2022
Q3 		$28K Buy
+1,766
New +$27.6K ﹤0.01% 2544
2022
Q2 		– Sell
-896
Closed -$14K – 2882
2022
Q1 		$14K Sell
896
-32
-3% -$553 ﹤0.01% 2960
2021
Q4 		$20K Buy
+928
New +$25.3K ﹤0.01% 2899

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return